Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12140804rdf:typepubmed:Citationlld:pubmed
pubmed-article:12140804lifeskim:mentionsumls-concept:C0008976lld:lifeskim
pubmed-article:12140804lifeskim:mentionsumls-concept:C0018801lld:lifeskim
pubmed-article:12140804lifeskim:mentionsumls-concept:C0025664lld:lifeskim
pubmed-article:12140804lifeskim:mentionsumls-concept:C1707689lld:lifeskim
pubmed-article:12140804lifeskim:mentionsumls-concept:C2699007lld:lifeskim
pubmed-article:12140804pubmed:issue3lld:pubmed
pubmed-article:12140804pubmed:dateCreated2002-7-25lld:pubmed
pubmed-article:12140804pubmed:abstractTextHydralazine and isosorbide dinitrate combination (H+ISDN), angiotensin-converting enzyme inhibitors, and beta-blockers have improved outcomes in heart failure (HF). Analysis of previous trials has shown that H+ISDN appears especially beneficial in African American patients.lld:pubmed
pubmed-article:12140804pubmed:languageenglld:pubmed
pubmed-article:12140804pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12140804pubmed:citationSubsetIMlld:pubmed
pubmed-article:12140804pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12140804pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12140804pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12140804pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12140804pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12140804pubmed:statusMEDLINElld:pubmed
pubmed-article:12140804pubmed:monthJunlld:pubmed
pubmed-article:12140804pubmed:issn1071-9164lld:pubmed
pubmed-article:12140804pubmed:authorpubmed-author:LoscalzoJosep...lld:pubmed
pubmed-article:12140804pubmed:authorpubmed-author:YancyClyde...lld:pubmed
pubmed-article:12140804pubmed:authorpubmed-author:CohnJay NJNlld:pubmed
pubmed-article:12140804pubmed:authorpubmed-author:OfiliElizabet...lld:pubmed
pubmed-article:12140804pubmed:authorpubmed-author:WorcelManuelMlld:pubmed
pubmed-article:12140804pubmed:authorpubmed-author:FranciosaJose...lld:pubmed
pubmed-article:12140804pubmed:authorpubmed-author:TaylorAnne...lld:pubmed
pubmed-article:12140804pubmed:authorpubmed-author:ZiescheSusanSlld:pubmed
pubmed-article:12140804pubmed:authorpubmed-author:OlukotunAdeoy...lld:pubmed
pubmed-article:12140804pubmed:authorpubmed-author:FerdinandKeit...lld:pubmed
pubmed-article:12140804pubmed:authorpubmed-author:A-HeFT...lld:pubmed
pubmed-article:12140804pubmed:issnTypePrintlld:pubmed
pubmed-article:12140804pubmed:volume8lld:pubmed
pubmed-article:12140804pubmed:ownerNLMlld:pubmed
pubmed-article:12140804pubmed:authorsCompleteYlld:pubmed
pubmed-article:12140804pubmed:pagination128-35lld:pubmed
pubmed-article:12140804pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:12140804pubmed:meshHeadingpubmed-meshheading:12140804...lld:pubmed
pubmed-article:12140804pubmed:meshHeadingpubmed-meshheading:12140804...lld:pubmed
pubmed-article:12140804pubmed:meshHeadingpubmed-meshheading:12140804...lld:pubmed
pubmed-article:12140804pubmed:meshHeadingpubmed-meshheading:12140804...lld:pubmed
pubmed-article:12140804pubmed:meshHeadingpubmed-meshheading:12140804...lld:pubmed
pubmed-article:12140804pubmed:meshHeadingpubmed-meshheading:12140804...lld:pubmed
pubmed-article:12140804pubmed:meshHeadingpubmed-meshheading:12140804...lld:pubmed
pubmed-article:12140804pubmed:meshHeadingpubmed-meshheading:12140804...lld:pubmed
pubmed-article:12140804pubmed:meshHeadingpubmed-meshheading:12140804...lld:pubmed
pubmed-article:12140804pubmed:meshHeadingpubmed-meshheading:12140804...lld:pubmed
pubmed-article:12140804pubmed:meshHeadingpubmed-meshheading:12140804...lld:pubmed
pubmed-article:12140804pubmed:meshHeadingpubmed-meshheading:12140804...lld:pubmed
pubmed-article:12140804pubmed:meshHeadingpubmed-meshheading:12140804...lld:pubmed
pubmed-article:12140804pubmed:meshHeadingpubmed-meshheading:12140804...lld:pubmed
pubmed-article:12140804pubmed:meshHeadingpubmed-meshheading:12140804...lld:pubmed
pubmed-article:12140804pubmed:meshHeadingpubmed-meshheading:12140804...lld:pubmed
pubmed-article:12140804pubmed:meshHeadingpubmed-meshheading:12140804...lld:pubmed
pubmed-article:12140804pubmed:meshHeadingpubmed-meshheading:12140804...lld:pubmed
pubmed-article:12140804pubmed:meshHeadingpubmed-meshheading:12140804...lld:pubmed
pubmed-article:12140804pubmed:year2002lld:pubmed
pubmed-article:12140804pubmed:articleTitleAfrican-American Heart Failure Trial (A-HeFT): rationale, design, and methodology.lld:pubmed
pubmed-article:12140804pubmed:affiliationZena and Michael A. Wiener Cardiovascular Institute, Mt. Sinai School of Medicine, New York, New York, USA.lld:pubmed
pubmed-article:12140804pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12140804pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:12140804pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:12140804pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12140804lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12140804lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12140804lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12140804lld:pubmed